DIA: Driving Insights to Action
Science:Life Sciences
Dr. Patrick Brady, Vice President of Regulatory Affairs at Bayer, chaired the DIA 2018 Global Annual Meeting session “The Future of PharmaTech” that explored how new technologies such as artificial intelligence, block chain, cloud computing, and “the internet of things,” are impacting the entire healthcare ecosystem. Dr. Brady discusses these technologies and their impacts with Dr. Sudip Parikh, Senior Vice President and Managing Director for DIA Americas, in the following podcast. Watch the video of this podcast interview.
Analyzing Innovation’s Progress in Gottlieb Era
Comparing Generic Safety Profile with Branded Cousin
Defining Unmet Need Critical to Determining Value
Triple-A RWE: Adequate Data, Appropriate Designs, Actionable Evidence
US REMS Requirements for NDAs and BLAs
Epoietin Biosimilars: Qualitative Study of Patients' Views
Disparities Between FDA/EMA Review Processes
DIA Japan's Focus in Fall 2018
FDA Leadership on Future Biologics and EMA/FDA Cooperation
Global Perspectives on Patient Engagement
DIA Board Chair Discusses DIA Now and Digital Tomorrow
Integrating Genetic Medicine into Clinical Care
Regulatory Landscape of Drug-Device Combination Products
Value-Based Assessment & Contracting: What Needs to Be Done?
“My Voice Needed to Be Heard”
IMEDS Collaboration Builds Upon Sentinel Surveillance
Crafting Sound Medical Affairs Professionals
Statistical Strategies for Using Sources of Safety Data
Regulatory & Ethical Considerations in a Pediatric Trial
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Speaking of Psychology
Stuff To Blow Your Mind